(NASDAQ: CBUS) Cibus's forecast annual revenue growth rate of 147.02% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.81%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.82%.
Cibus's revenue in 2025 is $4,153,000.On average, 2 Wall Street analysts forecast CBUS's revenue for 2025 to be $255,616,207, with the lowest CBUS revenue forecast at $67,710,944, and the highest CBUS revenue forecast at $443,521,470. On average, 2 Wall Street analysts forecast CBUS's revenue for 2026 to be $830,863,554, with the lowest CBUS revenue forecast at $94,617,914, and the highest CBUS revenue forecast at $1,567,109,194.
In 2027, CBUS is forecast to generate $1,939,962,910 in revenue, with the lowest revenue forecast at $1,425,773,686 and the highest revenue forecast at $2,454,152,134.